Actively Recruiting

Phase Not Applicable
Age: 6Years +
All Genders
NCT07018180

Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes

Led by CAPTEUR PROTECT · Updated on 2026-03-18

194

Participants Needed

7

Research Sites

56 weeks

Total Duration

On this page

Sponsors

C

CAPTEUR PROTECT

Lead Sponsor

I

Icadom

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of this clinical trial is to evaluate whether the COVER PATCH adhesive patch can improve the adhesion of continuous glucose monitors (CGMs). CGMs provide continuous blood sugar readings throughout the day and night, providing valuable data to help individuals manage their diabetes more efficiently. Many people face difficulties in keeping their CGM sensor in place. Factors such as sweat, physical activity, heat, skin creams, and swimming can cause the sensor to fall off prematurely, interrupting glucose monitoring and making it harder to maintain stable blood sugar levels. It has been shown that wearing a CGM sensor for at least 70% of the time is linked to better blood sugar control, measured by lower glycated hemoglobin (HbA1c). HbA1c reflects the average blood sugar over the past 3 months. A lower HbA1c level is associated with better diabetes management. Currently, CGM sensors are designed for one-time use and need to be replaced every 7 to 15 days. However, when sensors fall off prematurely, they need to be replaced more frequently, leading to higher costs for patients. This can exceed what is covered by insurance. Some patients use non-approved solutions, like extra adhesive tapes, to keep their sensors in place, but these methods may not be effective. This clinical trial aims to answer the following questions: * Does the adhesive patch help keep the CGM sensor in place for the full recommended duration? * Does better sensor adhesion lead to improved blood sugar control and lower HbA1c? * Does the patch help reduce the frequency of premature sensor replacements? To take part in this study, participants must be at least 6 years old and have type 1 or type 2 diabetes. Participants continue using their usual CGM during the study and are randomly assigned to either use the adhesive patch (COVER PATCH) or not. Participants and/or their parents (depending on the participant's age) complete questionnaires at the start of the study, and again at the end of the study at 4 months. Throughout the 4-month period, they also use an electronic tool (ePRO) to record each CGM sensor change and the reason for replacement. This study may help improve how well glucose sensors stay in place, reduce the need to change them too often, and make it easier to manage blood sugar. It also aims to fulfill a medical need that is currently not adequately covered.

CONDITIONS

Official Title

Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes

Who Can Participate

Age: 6Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female
  • At least 6 years old
  • Diagnosed with type 1 or type 2 diabetes
  • Currently using a continuous glucose monitoring (CGM) sensor
  • CGM sensor usage time < 70% over the last 4 months
  • HbA1c 6 8% (verified by blood test or capillary test, no older than one month at enrollment)
  • Owns a smartphone and has internet access for completing questionnaires
  • Covered by a social security scheme
  • Able to read, understand the study procedure, and give informed consent (or legal representative can consent)
Not Eligible

You will not qualify if you...

  • Serious and untreated skin issues where the device will be applied (e.g., psoriasis, herpetiform dermatitis, skin rash, staphylococcal infection)
  • Participated in an interventional clinical study within one month prior to enrollment that may impact this study
  • Deprived of liberty, under guardianship, or curatorship
  • Pregnant or breastfeeding women, or women of childbearing age without effective contraception or who do not agree to use contraception during the study (pregnancy will be checked by urine test for women under 60)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Hospices Civils de Lyon - Hôpital Femme Mère Enfant

Bron, France, 69677

Not Yet Recruiting

2

CH Sud Francilien

Corbeil-Essonnes, France, 91100

Actively Recruiting

3

CHU Grenoble Alpes

Grenoble, France, 38043

Not Yet Recruiting

4

AP-HM Hôpital La Timone - Enfants

Marseille, France, 13385

Not Yet Recruiting

5

CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, France, 34295

Not Yet Recruiting

6

CHU Toulouse - Hôpital de Rangueil

Toulouse, France, 31400

Not Yet Recruiting

7

CHU Guadeloupe

Pointe-à-Pitre, Guadeloupe, 97110

Not Yet Recruiting

Loading map...

Research Team

L

Laurie GUILLAUME

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here